Metsera
$1.80B
Develops obesity and cardiometabolic disease medicines
- $1.80B last priced transaction (>1yr old) (as of 2025-01)
- 5 sourced signals across 2 data sources
Loading the full interactive profile on VizierAtlas…
Develops obesity and cardiometabolic disease medicines
Loading the full interactive profile on VizierAtlas…